Rapid detection of rifampicin susceptibility of mycobacterium tuberculosis in sputum specimens by mycobacteriophage assay

Journal of the Pakistan Medical Association

Volumn 54, Issue 7, 2004, Pages 379-382

  Butt, T ^a   Ahmad, R N ^a   Afzal, R K ^a   Mahmood, A ^a   Anwar, M ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN;

ACCURACY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASSAY; BACTERIUM ISOLATE; COMPARATIVE STUDY; LUNG TUBERCULOSIS; MYCOBACTERIOPHAGE ASSAY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATIENT CARE; SPUTUM ANALYSIS;

ANTIBIOTICS, ANTITUBERCULAR; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIOPHAGES; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; SPUTUM; TUBERCULOSIS, PULMONARY;

EID: 4444303059     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. World Health Organization. The WHO/IUATLD global project on anti-tuberculosis surveillance: anti-tuberculosis drug resistance in the work report no. 2: prevalence and trends. Geneva: WHO., 2000.
2. Pablos-Mendez A, Raviglione MC, Laszlo A, et al. Global surveillance for anti-tuberculosis-drug resistance, 1994-1997. N Engl J Med 1998;338:1641-9.
3. Iseman MD. Treatment and implications of multidrug-resistant tuberculosis for the 21st century. Chemotherapy 1999;45 (Suppl 2):34-40.
4. Centers for Disease Control and Prevention. Initial therapy for tuberculosis in the era of multidrug-resistance. Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep 1993;42:RR7.
5. Rattan A, Kalia A, Ahmad N. Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives. Emerg Infect Dis 1998;4:195-209.
6. Heymann SJ, Brewer TF, Wilson ME, et al. The need for global action against multidrug-resistant tuberculosis. JAMA 1999;281:2138-41.
7. National Committee for Clinical Laboratory Standards. Antimycobacterial susceptibility testing for Mycobacterium tuberculosis. Tentative standard M24-T. Wayne, PA: The Committee; 2000.
8. Inderlied CB. Antimycobacterial susceptibility testing: present practices and future trends. Eur J Clin Microbiol Infect Dis 1994;13:980-93.
9. Walters SB, Hanna BA. Testing of susceptibility of mycobacterium tuberculosis to isoniazid and rifampicin by Mycobacterial Growth Indicator Tube Method J Clin Microbiol 1996;34:1565-67.
10. Albert H, Heydenrych A, Mole R, et al. Evaluation of FASTPlaqueTB-RIFTM, a rapid manual test for the determination of rifampicin resistance from Mycobacterium tuberculosis cultures. Int J Tuberc Lung Dis 2001;5:906-11.
11. Albert H, Trollip AP, Mole RJ, et al. Rapid indication of multidrug-resistant tuberculosis from liquid cultures using FASTPlaqueTB-RIFTM, a manual phage-based test. Int J Tuberc Lung Dis 2002;6:523-8.
12. Robert GD, Koneman EW, Kim YK. Mycobacterium. In: Balows A, Hausler WJ Jr, Herrmann KI, et al. editors. Manual of clinical microbiology. 5th ed. Washington, DC: American Society for Microbiology; 1991, pp. 304-39.
13. Siddiqi SH. BACTEC TB System. Product and procedure manual. Revision B. Becton Dickinson Diagnostic Instruments Systems, Towson, Md. USA; 1989.
14. Siddiqi SH. BACTEC NAP test. In: Isenberg HD, editor. Clinical microbiology procedures handbook. Vol 1. Washington, DC: American Society for Microbiology; 1992. pp. 3.13.1-3.13.4.
15. Watt B, Rayner A, Harris G. Mycobacterium. In: Collee JG, Fraser AG, Marmion BP, et al. MacKie and McCartney practical medical microbiology. 14th ed. Edinburgh: Churchill Livingstone; 1996, pp. 329-41.
16. Takiff H, Heifets L. In search of rapid diagnosis and drug resistance detection tools: is the FASTPlaqueTB test the answer? Int J Tuberc Lung Dis 2002;6:560-1.
17. Van Rie A, Warren R, Mshanga I, et al. Analysis of a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high incidence community. J Clin Microbiol 2001;39:636-41.